Oslo, Norway – 16 May 2024 - IDEX Biometrics will give a webcast presentation today at 09:00 CET in connection with its interim report for the first quarter of 2024. The presentation will be held by Vince Graziani, Chief Executive Officer, and Catharina Ekløf, Chief Commercial and Operating Officer. The webcast presentation can be viewed at the following link: https://idexbiometrics.videosync.fi/q1-2024 The presentation file is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors ...

Oslo, Norway – 16 May 2024 - IDEX Biometrics ASA's interim report for the first quarter of 2024 is attached to this notice (link below) The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A webcast presentation of the interim report will be held by Vince Graziani, Chief Executive Officer, today at 09:00 CET. The webcast presentation slide deck is attached to this notice (link below). Last year we focused on laying the foundation for biometri ...

Oslo, 15 May 2024 Reference is made to the stock exchange notice from IDEX Biometrics ASA ("IDEX" or the "Company") on 15 May 2024 regarding a private placement of shares in the Company raising approximately NOK 55 million at a subscription price of NOK 1.65 per share (the "Private Placement") and a possible subsequent offering, raising up to NOK 13,200,000, at the same subscription price as in the private placement (the "Subsequent Offering"), subject to approval by an Extraordinary General Meeting to be h ...

The board of directors of IDEX Biometrics ASA resolved on 15 May 2024 to issue 40,900 incentive subscription rights to a new individual contractor in the IDEX Biometrics group. The grant was made under the company's 2023 incentive subscription rights plan as resolved at the annual general meeting on 23 May 2023. The exercise price of the subscription rights is NOK 1.80 per share and the SRs vest by 25% per year over four years. The SRs expire on 23 May 2028. Following the grant there are 17,514,625 subscrip ...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 15 May 2024. Reference is made to the press release from IDEX Biometrics ASA ("IDEX" or the "Company") published earlier today, 15 May 2024, regarding a contemplated private placeme ...

IDEX Corporation (NYSE:IEX) Q1 2024 Earnings Conference Call April 24, 2024 10:30 AM ET Company Participants Wendy Palacios – Vice President-FP&A and Investor Relations Eric Ashleman – Chief Executive Officer and President Abhi Khandelwal – Senior Vice President and Chief Financial Officer Conference Call Participants Mike Halloran – Robert W. Baird Deane Dray – RBC Capital Markets Vlad Bystricky – Citigroup Nathan Jones – Stifel Joe Giordano – TD Cowen Matt Summerville – D.A. Davidson Rob Wertheimer – Meli ...

• Ag cyclically down Positive market signals continue excluding Agriculture *This presentation contains non-GAAP financial information. Reconciliations of non-GAAP measures are included either in this presentation or in our Q1 '24 earnings release. Click Here to Edit Title Q1 2024: Health & Science Technologies 7 ($ in millions) Orders -2% Organic* $351 $310 Q1'23 Q1'24 28.7%26.2% Q1'23 Q1'24 $318 $314 Q1'23 Q1'24 Sales Organic FX M&A YoY∆ Sales Growth -13% - 1% -12% Adj. EBITDA Margin* -250 bps Highlights ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-10235 IDEX CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of ...

IDEX Corporation’s (IEX) first-quarter 2024 adjusted earnings of $1.88 per share surpassed the Zacks Consensus Estimate of $1.75. The bottom line decreased approximately 10.1% from the year-ago quarter’s figure of $2.09. However, it exceeded management’s projection of $1.70-$1.75 per share.Revenue DetailsIn the quarter under review, IDEX’s net sales of $800.5 million underperformed the Zacks Consensus Estimate of $805 million.  The top line also decreased 5.3% year over year. Organic sales in the quarter de ...

For further information: TRADED: NYSE (IEX) EX-99.1 Investor Contact: Wendy Palacios Vice President FP&A and Investor Relations (847) 498-7070 IDEX REPORTS FIRST QUARTER RESULTS AND CONFIRMS FULL YEAR GUIDANCE Full Year and Second Quarter 2024 Outlook NORTHBROOK, IL, April 23, 2024 - IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended March 31, 2024. "Our IDEX teams delivered solid results in the first quarter, expanding margins within our Fluid & Metering Tec ...